Ocular Therapeutix plans wet AMD drug filing for late 2026

Go back to Ocular Therapeutix plans wet AMD drug filing for late 2026
(NASDAQ: OCUL) Delayed: 10.09 +0.66 (7.00%)
Previous Close $9.43    52 Week High $14.50 
Open $9.51    52 Week Low $4.04 
Day High $10.11    P/E N/A 
Day Low $9.41    EPS $0.00 
Volume 3,418,968